These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 24909149)
21. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone. Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436 [TBL] [Abstract][Full Text] [Related]
22. Fabrication of cationic nanomicelle from chitosan-graft-polycaprolactone as the carrier of 7-ethyl-10-hydroxy-camptothecin. Duan K; Zhang X; Tang X; Yu J; Liu S; Wang D; Li Y; Huang J Colloids Surf B Biointerfaces; 2010 Apr; 76(2):475-82. PubMed ID: 20047821 [TBL] [Abstract][Full Text] [Related]
23. Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and Safwat MA; Mansour HF; Hussein AK; Abdelwahab S; Soliman GM Drug Deliv; 2020 Dec; 27(1):1115-1124. PubMed ID: 32720545 [TBL] [Abstract][Full Text] [Related]
24. Y-shaped Folic Acid-Conjugated PEG-PCL Copolymeric Micelles for Delivery of Curcumin. Feng R; Zhu W; Chu W; Teng F; Meng N; Deng P; Song Z Anticancer Agents Med Chem; 2017; 17(4):599-607. PubMed ID: 27528180 [TBL] [Abstract][Full Text] [Related]
25. In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. Forrest ML; Won CY; Malick AW; Kwon GS J Control Release; 2006 Jan; 110(2):370-377. PubMed ID: 16298448 [TBL] [Abstract][Full Text] [Related]
26. Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycin. Yáñez JA; Forrest ML; Ohgami Y; Kwon GS; Davies NM Cancer Chemother Pharmacol; 2008 Jan; 61(1):133-44. PubMed ID: 17393166 [TBL] [Abstract][Full Text] [Related]
27. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors. Molavi O; Ma Z; Mahmud A; Alshamsan A; Samuel J; Lai R; Kwon GS; Lavasanifar A Int J Pharm; 2008 Jan; 347(1-2):118-27. PubMed ID: 17681440 [TBL] [Abstract][Full Text] [Related]
28. Morphological control of poly(ethylene glycol)-block-poly(epsilon-caprolactone) copolymer aggregates in aqueous solution. Fairley N; Hoang B; Allen C Biomacromolecules; 2008 Sep; 9(9):2283-91. PubMed ID: 18702541 [TBL] [Abstract][Full Text] [Related]
29. Characterizing poly(epsilon-caprolactone)-b-chitooligosaccharide-b-poly(ethylene glycol) (PCP) copolymer micelles for doxorubicin (DOX) delivery: effects of crosslinked of amine groups. Chung TW; Liu DZ; Hsieh JH; Fan XC; Yang JD; Chen JH J Nanosci Nanotechnol; 2006; 6(9-10):2902-11. PubMed ID: 17048497 [TBL] [Abstract][Full Text] [Related]
30. Stabilization of poly(ethylene glycol)-poly(ε-caprolactone) star block copolymer micelles via aromatic groups for improved drug delivery properties. Buwalda S; Al Samad A; El Jundi A; Bethry A; Bakkour Y; Coudane J; Nottelet B J Colloid Interface Sci; 2018 Mar; 514():468-478. PubMed ID: 29289031 [TBL] [Abstract][Full Text] [Related]
31. Solubilization of an amphiphilic drug by poly(ethylene oxide)-block-poly(ester) micelles. Elhasi S; Astaneh R; Lavasanifar A Eur J Pharm Biopharm; 2007 Mar; 65(3):406-13. PubMed ID: 17291732 [TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterization, and application of amino-terminated poly(ethylene glycol)-block-poly(epsilon-caprolactone) copolymer for paclitaxel. Wang C; Liang J; Deng X; Long C; Xie C; Chen X; Zhang L; Guo Q; Wang Y; Wang Y; Luo F; Qian Z J Nanosci Nanotechnol; 2013 Jan; 13(1):68-76. PubMed ID: 23646699 [TBL] [Abstract][Full Text] [Related]
33. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties. Zhang W; Li Y; Liu L; Sun Q; Shuai X; Zhu W; Chen Y Biomacromolecules; 2010 May; 11(5):1331-8. PubMed ID: 20405912 [TBL] [Abstract][Full Text] [Related]
34. Microemulsion loaded hydrogel as a promising vehicle for dermal delivery of the antifungal sertaconazole: design, optimization and ex vivo evaluation. Radwan SAA; ElMeshad AN; Shoukri RA Drug Dev Ind Pharm; 2017 Aug; 43(8):1351-1365. PubMed ID: 28420288 [TBL] [Abstract][Full Text] [Related]
35. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo. Tang X; Zhu H; Sun L; Hou W; Cai S; Zhang R; Liu F Int J Nanomedicine; 2014; 9():5403-13. PubMed ID: 25473279 [TBL] [Abstract][Full Text] [Related]
36. Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles. Moretton MA; Glisoni RJ; Chiappetta DA; Sosnik A Colloids Surf B Biointerfaces; 2010 Sep; 79(2):467-79. PubMed ID: 20627665 [TBL] [Abstract][Full Text] [Related]
37. Solutol HS15 based binary mixed micelles with penetration enhancers for augmented corneal delivery of sertaconazole nitrate: optimization, in vitro, ex vivo and in vivo characterization. Younes NF; Abdel-Halim SA; Elassasy AI Drug Deliv; 2018 Nov; 25(1):1706-1717. PubMed ID: 30442039 [TBL] [Abstract][Full Text] [Related]
38. Doxorubicin delivery via magnetic nanomicelles comprising from reduction-responsive poly(ethylene glycol)‑b‑poly(ε‑caprolactone) (PEG-SS-PCL) and loaded with superparamagnetic iron oxide (SPIO) nanoparticles: Preparation, characterization and simulation. Mousavi SD; Maghsoodi F; Panahandeh F; Yazdian-Robati R; Reisi-Vanani A; Tafaghodi M Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():631-643. PubMed ID: 30184790 [TBL] [Abstract][Full Text] [Related]
39. Characterization of the self assembly of methoxy poly(ethylene oxide)-block-poly(α-benzyl carboxylate-ε-caprolactone) for the solubilization and in vivo delivery of valspodar. Binkhathlan Z; Elhasi S; Brocks DR; Lavasanifar A Curr Drug Deliv; 2012 Mar; 9(2):164-71. PubMed ID: 22283648 [TBL] [Abstract][Full Text] [Related]
40. Solubilization of sagopilone, a poorly water-soluble anticancer drug, using polymeric micelles for parenteral delivery. Richter A; Olbrich C; Krause M; Kissel T Int J Pharm; 2010 Apr; 389(1-2):244-53. PubMed ID: 20100557 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]